Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by qwerty22on Jan 13, 2021 3:30pm
154 Views
Post# 32287053

RE:The dreadful deal

RE:The dreadful deal

I'm no expert on raising money so I take what the level headed (if fuming), experienced guys say.

It seems this deal fits the pattern of a small, desparate, provincial, Canadian biotech despately failing to be taken seriously by the big serious US-based biotech ecosystem. This deal basically re-confirms what Theratech are. Maybe they don't get to eat from the banqueting table, maybe they just get the fallen crumbs.


SPCEO1 wrote: I thought I would share this comment from a friend of another major THTX shareholder I know. His friend is a portfolio manager at a major firm in the US:

My PM friend from (I removed the firm's name) ( he manages 5 billion 4 time all star ) called me today.  After a quick “ look see “ yesterday didn’t see anything good about the deal.  Today he called and said he devoted an hour last night studying everything and said “ therf gave away the farm when they didn’t have too and they royally screwed existing shareholders when they didn’t have too “
 
He said as promising as the company looks he would probably avoid it bc of  this incredibly poor deal they put together.  I couldn’t answer him when he said they had a shot to play in the big leagues and deal with piper / Raymond James  /  etc.  they ran back to Canada.  He can’t figure that out and asked why even bother to be on the nasdaq if you don’t want to play with the big boys ?
 
He asked if something could have gone wrong that I don’t know about bc it looks to him like a panicked / rushed / too good to be true deal.  I told him I wasn’t aware of anything that panicked the leadership.  He was gobsmacked they haven’t reached out to major shareholders

 

<< Previous
Bullboard Posts
Next >>